Curtis, Elizabeth M. http://orcid.org/0000-0002-5147-0550
Reginster, Jean-Yves http://orcid.org/0000-0001-6290-752X
Al-Daghri, Nasser http://orcid.org/0000-0001-5472-1725
Biver, Emmanuel http://orcid.org/0000-0001-6174-1951
Brandi, Maria Luisa http://orcid.org/0000-0002-8741-0592
Cavalier, Etienne http://orcid.org/0000-0003-0947-2226
Hadji, Peyman http://orcid.org/0000-0003-4787-3151
Halbout, Philippe
Harvey, Nicholas C. http://orcid.org/0000-0002-8194-2512
Hiligsmann, Mickaël http://orcid.org/0000-0003-4274-9258
Javaid, M. Kassim http://orcid.org/0000-0001-7985-0048
Kanis, John A. http://orcid.org/0000-0002-3129-4326
Kaufman, Jean-Marc http://orcid.org/0000-0002-1400-6812
Lamy, Olivier
Matijevic, Radmila http://orcid.org/0000-0002-4993-9399
Perez, Adolfo Diez
Radermecker, Régis Pierre http://orcid.org/0000-0002-2866-8171
Rosa, Mário Miguel
Thomas, Thierry http://orcid.org/0000-0001-5959-9183
Thomasius, Friederike
Vlaskovska, Mila
Rizzoli, René http://orcid.org/0000-0002-1537-422X
Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Funding for this research was provided by:
no funding source
Article History
Received: 11 February 2022
Accepted: 18 February 2022
First Online: 24 March 2022
Declarations
:
: E.M.C. reports lecture fees and travel support from Eli Lilly, Pfizer and UCB, outside the submitted work. N.A.D. reports no conflict of interest. E.B. reports lecture fees from Amgen, outside the submitted work. M.L.B. reports honoraria from Amgen, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB, grants or speaker fees from Abiogen, Alexion, Amgen, Bruno Farmaceutici, Echolight, Eli Lilly, Kyowa Kirin, SPA, Theramex, UCB and consulting fees from Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Kyowa Kirin, UCB, outside the submitted work. E.C. EC is consultant for DiaSorin, IDS, Fujirebio and Nittobo. P.Hadji. reports personal fees, consultancy, lecture fees and honoraria from AMGEN, Eli Lilly, Fresenius, Gedeon Richter, Hexal, MSD, Novartis, Roche, Stada, Theramex, UCB, outside the submitted work. P. Halbout reports no conflict of interest. N.C.H. reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Consilient Healthcare and Internis Pharma, outside the submitted work. MKJ reports personal fees from Amgen, UCB and Besin Healthcare institutional grant support from Amgen and UCB outside of the submitted work. M.H. has received research grants through institution from Amgen, Radius Health, BD, ViiV Healthcare, lecture fees from Teva and Mylan, and consulting fees from UCB outside the submitted work. M.K.J. reports no conflict of interest. J.A.K.: Nothing to declare. JAK is the architect of FRAX® but has no financial interest. J-M.K. reports no conflict of interest in relation to the submitted work. O.L. reports no conflict of interest. R.M. reports no conflict of interest. A.D-P. reports lecture fees from Eli Lilly, Amgen and Gedeon Richter outside the submitted work. R.P.R.: Nothing to declare for the submitted work. M.R. reports no conflict of interest in relation to the submitted work. T.T. has received consultancy/speaker’s fees from Amgen, Arrow, Biogen, Chugai, Expanscience, Grunenthal, Jansen, LCA, Lilly, MSD, Nordic, Novartis, Pfizer, Sanofi, Thuasne, Theramex, TEVA et UCB and financial support or fees for research activities from: Bone Therapeutics, Chugai, UCB. F.T. reports personal fees, consultancy, lecture fees and honoraria from AMGEN, Fresenius, Gedeon-Richter, Hexal, HOLOGIC, Kyowa-Kirin, Stadapharm, Theramex, UCB, outside the submitted work. M.V. reports no conflict of interest in relation to the submitted work. J.Y.R. has received fees for lectures or advisory boards from IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvinate Biomed, Teva, Theramex, Pfizer, Mithra Pharmaceuticals, CNIEL, Dairy Research Council, Nutricia, Danone and Agnovos, and industry grants (all through institution) from IBSA-Genevrier, Mylan, CNIEL, Radius Health and TRB, outside the submitted work. R.R. has received fees for lectures or advisory boards from Abiogen, Amgen, Danone, Echolight, European Milk Forum, Mithra, Nestlé, ObsEva, Pfizer Consumer Health, Radius Health, Rejunevate and Theramex. C.C. reports personal fees from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier and Takeda, outside the submitted work.
: This narrative article contains no original data and thus issues of ethics, informed consent and patient confidentiality do not apply.